Ascentage Pharma Group International (NASDAQ:AAPG) Sees Unusually-High Trading Volume – Should You Buy?

Shares of Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) saw strong trading volume on Thursday. 4,501 shares traded hands during trading, a decline of 34% from the previous session’s volume of 6,784 shares. The stock last traded at $14.62 and had previously closed at $14.85.

Analysts Set New Price Targets

Several research analysts have commented on AAPG shares. Citigroup initiated coverage on shares of Ascentage Pharma Group International in a research note on Tuesday. They set a “buy” rating and a $46.00 price target on the stock. BTIG Research reaffirmed a “buy” rating and set a $48.00 target price on shares of Ascentage Pharma Group International in a report on Friday, August 21st. Citizens Jmp initiated coverage on shares of Ascentage Pharma Group International in a research report on Tuesday. They issued a “market outperform” rating and a $35.00 target price on the stock. Finally, JPMorgan Chase & Co. decreased their target price on shares of Ascentage Pharma Group International from $46.00 to $33.00 and set an “overweight” rating on the stock in a research report on Thursday, October 8th. Two equities research analysts have rated the stock with a Strong Buy rating and eleven have assigned a Buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $43.90.

Ascentage Pharma Group International Stock Performance

The company has a debt-to-equity ratio of 1.09, a current ratio of 1.22 and a quick ratio of 1.18. The stock has a 50-day moving average price of $16.60 and a two-hundred day moving average price of $19.17.

Ascentage Pharma Group International (NASDAQ:AAPG) last announced its earnings results on Wednesday, August 19th. The company reported ($0.65) EPS for the quarter. The company had revenue of $22.24 million during the quarter. Research analysts forecast that Ascentage Pharma Group International – Unsponsored ADR will post -2.42 earnings per share for the current year.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for cancer and other serious diseases.